Unlabelled: Recent shifts in US policy and digital platforms are making obesity medications more affordable. In this News and Perspectives article, JMIR Correspondent Xiangming Jenny Zhan reports on this emerging access model and its potential implications.
Xiangming Jenny Zhan (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: